vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and IMAX CORP (IMAX). Click either name above to swap in a different company.

CareTrust REIT, Inc. is the larger business by last-quarter revenue ($134.9M vs $125.2M, roughly 1.1× IMAX CORP). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 0.5%, a 82.0% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 35.1%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 25.8%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.

CTRE vs IMAX — Head-to-Head

Bigger by revenue
CTRE
CTRE
1.1× larger
CTRE
$134.9M
$125.2M
IMAX
Growing faster (revenue YoY)
CTRE
CTRE
+20.0% gap
CTRE
55.1%
35.1%
IMAX
Higher net margin
CTRE
CTRE
82.0% more per $
CTRE
82.5%
0.5%
IMAX
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
25.8%
IMAX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTRE
CTRE
IMAX
IMAX
Revenue
$134.9M
$125.2M
Net Profit
$111.3M
$637.0K
Gross Margin
57.6%
Operating Margin
19.3%
Net Margin
82.5%
0.5%
Revenue YoY
55.1%
35.1%
Net Profit YoY
113.5%
-88.0%
EPS (diluted)
$0.52
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
IMAX
IMAX
Q4 25
$134.9M
$125.2M
Q3 25
$132.4M
$106.7M
Q2 25
$112.5M
$91.7M
Q1 25
$96.6M
$86.7M
Q4 24
$86.9M
$92.7M
Q3 24
$77.4M
$91.5M
Q2 24
$68.9M
$89.0M
Q1 24
$63.1M
$79.1M
Net Profit
CTRE
CTRE
IMAX
IMAX
Q4 25
$111.3M
$637.0K
Q3 25
$74.9M
$20.7M
Q2 25
$68.5M
$11.3M
Q1 25
$65.8M
$2.3M
Q4 24
$52.1M
$5.3M
Q3 24
$33.4M
$13.9M
Q2 24
$10.8M
$3.6M
Q1 24
$28.7M
$3.3M
Gross Margin
CTRE
CTRE
IMAX
IMAX
Q4 25
57.6%
Q3 25
63.1%
Q2 25
58.5%
Q1 25
61.4%
Q4 24
52.2%
Q3 24
55.8%
Q2 24
49.4%
Q1 24
59.3%
Operating Margin
CTRE
CTRE
IMAX
IMAX
Q4 25
19.3%
Q3 25
58.1%
27.2%
Q2 25
61.3%
15.6%
Q1 25
19.3%
Q4 24
10.3%
Q3 24
43.0%
21.2%
Q2 24
15.1%
3.2%
Q1 24
15.3%
Net Margin
CTRE
CTRE
IMAX
IMAX
Q4 25
82.5%
0.5%
Q3 25
56.6%
19.4%
Q2 25
60.9%
12.3%
Q1 25
68.1%
2.7%
Q4 24
60.0%
5.7%
Q3 24
43.2%
15.2%
Q2 24
15.6%
4.0%
Q1 24
45.6%
4.1%
EPS (diluted)
CTRE
CTRE
IMAX
IMAX
Q4 25
$0.52
$0.02
Q3 25
$0.35
$0.37
Q2 25
$0.35
$0.20
Q1 25
$0.35
$0.04
Q4 24
$0.30
$0.09
Q3 24
$0.21
$0.26
Q2 24
$0.07
$0.07
Q1 24
$0.22
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
IMAX
IMAX
Cash + ST InvestmentsLiquidity on hand
$198.0M
$151.2M
Total DebtLower is stronger
$894.2M
Stockholders' EquityBook value
$4.0B
$337.9M
Total Assets
$5.1B
$894.0M
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
IMAX
IMAX
Q4 25
$198.0M
$151.2M
Q3 25
$712.5M
$143.1M
Q2 25
$306.1M
$109.3M
Q1 25
$26.5M
$97.1M
Q4 24
$213.8M
$100.6M
Q3 24
$377.1M
$104.5M
Q2 24
$495.1M
$91.6M
Q1 24
$451.2M
$81.0M
Total Debt
CTRE
CTRE
IMAX
IMAX
Q4 25
$894.2M
Q3 25
$893.8M
Q2 25
$1.2B
Q1 25
$822.1M
Q4 24
$396.9M
Q3 24
$396.7M
Q2 24
$671.1M
Q1 24
$595.9M
Stockholders' Equity
CTRE
CTRE
IMAX
IMAX
Q4 25
$4.0B
$337.9M
Q3 25
$4.0B
$349.5M
Q2 25
$3.3B
$320.4M
Q1 25
$2.9B
$299.5M
Q4 24
$2.9B
$299.5M
Q3 24
$2.4B
$289.4M
Q2 24
$1.9B
$267.2M
Q1 24
$1.7B
$258.8M
Total Assets
CTRE
CTRE
IMAX
IMAX
Q4 25
$5.1B
$894.0M
Q3 25
$5.1B
$889.6M
Q2 25
$4.7B
$868.6M
Q1 25
$3.9B
$848.3M
Q4 24
$3.4B
$830.4M
Q3 24
$2.9B
$847.6M
Q2 24
$2.7B
$827.4M
Q1 24
$2.3B
$824.1M
Debt / Equity
CTRE
CTRE
IMAX
IMAX
Q4 25
0.22×
Q3 25
0.22×
Q2 25
0.35×
Q1 25
0.28×
Q4 24
0.14×
Q3 24
0.16×
Q2 24
0.35×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
IMAX
IMAX
Operating Cash FlowLast quarter
$394.0M
$29.4M
Free Cash FlowOCF − Capex
$28.0M
FCF MarginFCF / Revenue
22.3%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
3.54×
46.11×
TTM Free Cash FlowTrailing 4 quarters
$118.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
IMAX
IMAX
Q4 25
$394.0M
$29.4M
Q3 25
$100.9M
$67.5M
Q2 25
$100.8M
$23.2M
Q1 25
$71.4M
$7.0M
Q4 24
$244.3M
$11.5M
Q3 24
$67.2M
$35.3M
Q2 24
$53.0M
$35.0M
Q1 24
$48.8M
$-11.0M
Free Cash Flow
CTRE
CTRE
IMAX
IMAX
Q4 25
$28.0M
Q3 25
$64.8M
Q2 25
$20.9M
Q1 25
$5.3M
Q4 24
$6.9M
Q3 24
$34.2M
Q2 24
$33.5M
Q1 24
$-12.1M
FCF Margin
CTRE
CTRE
IMAX
IMAX
Q4 25
22.3%
Q3 25
60.7%
Q2 25
22.8%
Q1 25
6.1%
Q4 24
7.4%
Q3 24
37.3%
Q2 24
37.6%
Q1 24
-15.3%
Capex Intensity
CTRE
CTRE
IMAX
IMAX
Q4 25
1.1%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
1.9%
Q4 24
5.0%
Q3 24
1.2%
Q2 24
1.8%
Q1 24
1.4%
Cash Conversion
CTRE
CTRE
IMAX
IMAX
Q4 25
3.54×
46.11×
Q3 25
1.35×
3.27×
Q2 25
1.47×
2.06×
Q1 25
1.08×
2.99×
Q4 24
4.68×
2.16×
Q3 24
2.01×
2.54×
Q2 24
4.92×
9.78×
Q1 24
1.70×
-3.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRE
CTRE

Segment breakdown not available.

IMAX
IMAX

Technology Sales$46.6M37%
Image Enhancement And Maintenance Services$38.1M30%
Joint Revenue Sharing Arrangement$20.4M16%
Maintenance$16.3M13%
Finance Income$2.8M2%
Other Content Solutions$1.6M1%

Related Comparisons